Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CX717 in Adults With ADHD
NCT03375021Phase 2Completed
- Sponsor
- RespireRx Pharmaceuticals
- Start
- Jul 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of CX-717 in attention deficit hyperactivity disorder (ADHD), sponsored by RespireRx Pharmaceuticals. Started Jul 2005; status: completed.
02
Drugs
CX-717
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03375021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03375021.